Skip to search formSkip to main contentSkip to account menu

Trientine hydrochloride

Known as: N,N-bis (2-aminoethyl)-1,2-ethanediamine Dihydrochloride, Trientine Dihydrochloride, trientine hcl 
The hydrochloride salt form of a metal chelating agent with potential anti-angiogenic activity. Trientine chelates excess copper (Cu) ions in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Addressing Generic-Drug Market Failures One market-based solution to stimulating competition in generic-drug markets is to… 
2005
2005
Recent studies have suggested that an anti-angiogenic agent could improve the inhibitory effects of standard chemotherapeutic… 
2003
2003
It has been shown that angiogenesis plays an important role not only in tumor growth, but also in carcinogenesis. We previously… 
Highly Cited
2001
Highly Cited
2001
Angiogenesis is now recognized as a crucial process in tumor development, including hepatocellular carcinoma (HCC). Since HCC is… 
1997
1997
Trientine dihydrochloride is used to treat Wilson's disease by chelating copper and increasing its urinary excretion. The… 
Highly Cited
1996
Highly Cited
1996
Trientine dihydrochloride (trientine) is an alternative medicinal copper chelating agent for patients with Wilson's disease of… 
1994
1994
Superficial hemosiderosis (SH) of the CNS is a rare disease caused by repeated subarachnoid hemorrhage, with progressive… 
1994
1994
Wilson disease (McKusick 277900) is an autosomal recessive disorder in which the biliary excretion of copper and its…